Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 3/2015

01.09.2015

Electrolyte and hemodynamic changes following percutaneous left atrial appendage ligation with the LARIAT device

verfasst von: Ryan Maybrook, Jayasree Pillarisetti, Vivek Yarlagadda, Sampath Gunda, Arun Raghav Mahankali Sridhar, Brent Deibert, Muhammad R. Afzal, Madhu Reddy, Donita Atkins, Matthew Earnest, Ryan Ferrell, Jayant Nath, Arun Kanmanthareddy, Sudharani Bommana, Rajasingh Johnson, Sandeep Reddy Koripalli, Buddhadeb Dawn, Dhanunjaya Lakkireddy

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The left atrial appendage (LAA) is a well-known source of atrial natriuretic peptide (ANP) and therefore plays an important role in homeostasis. The neurohormonal impact of epicardial exclusion of the LAA with the LARIAT procedure is unknown. In this proof-of-concept study, we postulated that LAA exclusion would impact homeostasis as evidenced by changes in electrolytes and blood pressure (BP).

Methods

A total of 76 patients who underwent successful LAA exclusion were enrolled in this retrospective observational study utilizing a prospective registry. Electrolytes, BP, and heart rate (HR) were monitored before LARIAT and post-LARIAT (24 and 72 h and 6 months).

Results

There was a significant reduction of systolic BP (mmHg) at 24 h (113.3 ± 16.0; p < 0.0001) and 72 h (119.0 ± 18.4 mmHg; p < 0.0001) post-LARIAT when compared with pre-LARIAT BP (138.2 ± 21.3). The reduction in systolic BP persisted at 6-month follow-up (128.8 ± 17.3; p = 0.0005). There was significant reduction in serum sodium (mmol/L) at 24 h (135.4 ± 3.6; p < 0.0001) and 72 h (136.3 ± 3.7; p < 0.001) post-LARIAT when compared to pre-LARIAT (138.7 ± 3.2). The reduction in sodium was not persistent at 6-month follow-up (138.4 ± 3.3; p = 0.453).

Conclusions

LAA exclusion results in an early and persistent decrease in systolic BP. Additionally, there is an early decline in serum sodium, which normalizes at long-term follow-up. The underlying mechanism leading to these changes is not entirely clear; however, it is likely related to neurohormonal changes post LAA exclusion.
Literatur
1.
Zurück zum Zitat Sadler, T. W., & Langman, J. (2004). Langman’s medical embryology (Vol. v. 1). Baltimore: Lippincott Williams & Wilkins. Sadler, T. W., & Langman, J. (2004). Langman’s medical embryology (Vol. v. 1). Baltimore: Lippincott Williams & Wilkins.
2.
Zurück zum Zitat Fang, M. C., Stafford, R. S., Ruskin, J. N., & Singer, D. E. (2004). National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation. Archives of Internal Medicine, 164(1), 55–60.PubMedCrossRef Fang, M. C., Stafford, R. S., Ruskin, J. N., & Singer, D. E. (2004). National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation. Archives of Internal Medicine, 164(1), 55–60.PubMedCrossRef
3.
Zurück zum Zitat Desai, N. R., Krumme, A. A., Schneeweiss, S., Shrank, W. H., Brill, G., Pezalla, E. J., et al. (2014). Patterns of initiation of oral anticoagulants in patients with atrial fibrillation—quality and cost implications. American Journal of Medicine. Desai, N. R., Krumme, A. A., Schneeweiss, S., Shrank, W. H., Brill, G., Pezalla, E. J., et al. (2014). Patterns of initiation of oral anticoagulants in patients with atrial fibrillation—quality and cost implications. American Journal of Medicine.
4.
Zurück zum Zitat Massumi, A., Chelu, M. G., Nazeri, A., May, S. A., Afshar-Kharaghan, H., Saeed, M., et al. (2013). Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation. American Journal of Cardiology, 111(6), 869–873.PubMedCrossRef Massumi, A., Chelu, M. G., Nazeri, A., May, S. A., Afshar-Kharaghan, H., Saeed, M., et al. (2013). Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation. American Journal of Cardiology, 111(6), 869–873.PubMedCrossRef
5.
Zurück zum Zitat Bartus, K., Han, F. T., Bednarek, J., Myc, J., Kapelak, B., Sadowski, J., et al. (2013). Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience. Journal of the American College of Cardiology, 62(2), 108–118.PubMedCrossRef Bartus, K., Han, F. T., Bednarek, J., Myc, J., Kapelak, B., Sadowski, J., et al. (2013). Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience. Journal of the American College of Cardiology, 62(2), 108–118.PubMedCrossRef
6.
Zurück zum Zitat Bartus, K., Bednarek, J., Myc, J., Kapelak, B., Sadowski, J., Lelakowski, J., et al. (2011). Feasibility of closed-chest ligation of the left atrial appendage in humans. Heart Rhythm, 8(2), 188–193.PubMedCrossRef Bartus, K., Bednarek, J., Myc, J., Kapelak, B., Sadowski, J., Lelakowski, J., et al. (2011). Feasibility of closed-chest ligation of the left atrial appendage in humans. Heart Rhythm, 8(2), 188–193.PubMedCrossRef
7.
Zurück zum Zitat Han, F. T., Bartus, K., Lakkireddy, D., Rojas, F., Bednarek, J., Kapelak, B., et al. (2014). The effects of LAA ligation on LAA electrical activity. Heart Rhythm, 11(5), 864–870.PubMedCrossRef Han, F. T., Bartus, K., Lakkireddy, D., Rojas, F., Bednarek, J., Kapelak, B., et al. (2014). The effects of LAA ligation on LAA electrical activity. Heart Rhythm, 11(5), 864–870.PubMedCrossRef
8.
Zurück zum Zitat Yoshihara, F., Nishikimi, T., Kosakai, Y., Isobe, F., Matsuoka, H., Takishita, S., et al. (1998). Atrial natriuretic peptide secretion and body fluid balance after bilateral atrial appendectomy by the maze procedure. Journal of Thoracic and Cardiovascular Surgery, 116(2), 213–219.PubMedCrossRef Yoshihara, F., Nishikimi, T., Kosakai, Y., Isobe, F., Matsuoka, H., Takishita, S., et al. (1998). Atrial natriuretic peptide secretion and body fluid balance after bilateral atrial appendectomy by the maze procedure. Journal of Thoracic and Cardiovascular Surgery, 116(2), 213–219.PubMedCrossRef
9.
Zurück zum Zitat Nakamura, M., Niinuma, H., Chiba, M., Ueshima, K., Arakawa, N., Yagi, Y., et al. (1997). Effect of the maze procedure for atrial fibrillation on atrial and brain natriuretic peptide. American Journal of Cardiology, 79(7), 966–970.PubMedCrossRef Nakamura, M., Niinuma, H., Chiba, M., Ueshima, K., Arakawa, N., Yagi, Y., et al. (1997). Effect of the maze procedure for atrial fibrillation on atrial and brain natriuretic peptide. American Journal of Cardiology, 79(7), 966–970.PubMedCrossRef
10.
Zurück zum Zitat Hocini, M., Shah, A. J., Nault, I., Sanders, P., Wright, M., Narayan, S. M., et al. (2011). Localized reentry within the left atrial appendage: arrhythmogenic role in patients undergoing ablation of persistent atrial fibrillation. Heart Rhythm, 8(12), 1853–1861.PubMedCentralPubMedCrossRef Hocini, M., Shah, A. J., Nault, I., Sanders, P., Wright, M., Narayan, S. M., et al. (2011). Localized reentry within the left atrial appendage: arrhythmogenic role in patients undergoing ablation of persistent atrial fibrillation. Heart Rhythm, 8(12), 1853–1861.PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat Kamohara, K., Popović, Z. B., Daimon, M., Martin, M., Ootaki, Y., Akiyama, M., et al. Impact of left atrial appendage exclusion on left atrial function. Journal of Thoracic and Cardiovascular Surgery, 133(1), 174–181. Kamohara, K., Popović, Z. B., Daimon, M., Martin, M., Ootaki, Y., Akiyama, M., et al. Impact of left atrial appendage exclusion on left atrial function. Journal of Thoracic and Cardiovascular Surgery, 133(1), 174–181.
12.
Zurück zum Zitat Khattab, A. A., & Meier, B. (2010). Transcatheter left atrial appendage exclusion, gold or fool’s gold? European Heart Journal Supplements, 12(suppl E), E35–E40.CrossRef Khattab, A. A., & Meier, B. (2010). Transcatheter left atrial appendage exclusion, gold or fool’s gold? European Heart Journal Supplements, 12(suppl E), E35–E40.CrossRef
13.
Zurück zum Zitat Al-Saady, N. M., Obel, O. A., & Camm, A. J. (1999). Left atrial appendage: structure, function, and role in thromboembolism. Heart, 82(5), 547–554.PubMedCentralPubMedCrossRef Al-Saady, N. M., Obel, O. A., & Camm, A. J. (1999). Left atrial appendage: structure, function, and role in thromboembolism. Heart, 82(5), 547–554.PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat de Bold, A. J., Bruneau, B. G., & Kuroski de Bold, M. L. (1996). Mechanical and neuroendocrine regulation of the endocrine heart. Cardiovascular Research, 31(1), 7–18.PubMedCrossRef de Bold, A. J., Bruneau, B. G., & Kuroski de Bold, M. L. (1996). Mechanical and neuroendocrine regulation of the endocrine heart. Cardiovascular Research, 31(1), 7–18.PubMedCrossRef
15.
Zurück zum Zitat Saito, Y. (2010). Roles of atrial natriuretic peptide and its therapeutic use. Journal of Cardiology, 56(3), 262–270.PubMedCrossRef Saito, Y. (2010). Roles of atrial natriuretic peptide and its therapeutic use. Journal of Cardiology, 56(3), 262–270.PubMedCrossRef
16.
Zurück zum Zitat Tabata, T., Oki, T., Yamada, H., Abe, M., Onose, Y., & Thomas, J. D. (2000). Relationship between left atrial appendage function and plasma concentration of atrial natriuretic peptide. European Journal of Echocardiography, 1(2), 130–137.PubMedCrossRef Tabata, T., Oki, T., Yamada, H., Abe, M., Onose, Y., & Thomas, J. D. (2000). Relationship between left atrial appendage function and plasma concentration of atrial natriuretic peptide. European Journal of Echocardiography, 1(2), 130–137.PubMedCrossRef
17.
Zurück zum Zitat Sakellaridis, T., Argiriou, M., Charitos, C., Tsakiridis, K., Zarogoulidis, P., Katsikogiannis, N., et al. (2014). Left atrial appendage exclusion-where do we stand? Journal of Thoracic Diseases, 6(Suppl 1), S70–S77. Sakellaridis, T., Argiriou, M., Charitos, C., Tsakiridis, K., Zarogoulidis, P., Katsikogiannis, N., et al. (2014). Left atrial appendage exclusion-where do we stand? Journal of Thoracic Diseases, 6(Suppl 1), S70–S77.
18.
Zurück zum Zitat Ramnarain, D., & Mehra, N. (2011). Natriuretic peptide-induced hyponatremia in a patient with left atrial myxoma. Critical Care, 15(1), 1–190.CrossRef Ramnarain, D., & Mehra, N. (2011). Natriuretic peptide-induced hyponatremia in a patient with left atrial myxoma. Critical Care, 15(1), 1–190.CrossRef
19.
Zurück zum Zitat Hannon, M. J., Behan, L. A., O’Brien, M. M., Tormey, W., Ball, S. G., Javadpur, M., et al. (2014). Hyponatremia following mild/moderate subarachnoid hemorrhage is due to SIAD and glucocorticoid deficiency and not cerebral salt wasting. Journal of Clinical Endocrinology and Metabolism, 99(1), 291–298.PubMedCrossRef Hannon, M. J., Behan, L. A., O’Brien, M. M., Tormey, W., Ball, S. G., Javadpur, M., et al. (2014). Hyponatremia following mild/moderate subarachnoid hemorrhage is due to SIAD and glucocorticoid deficiency and not cerebral salt wasting. Journal of Clinical Endocrinology and Metabolism, 99(1), 291–298.PubMedCrossRef
20.
Zurück zum Zitat Cesar, K. R., & Magaldi, A. J. (1999). Thiazide induces water absorption in the inner medullary collecting duct of normal and Brattleboro rats. American Journal of Physiology, 277(5 Pt 2), F756–F760.PubMed Cesar, K. R., & Magaldi, A. J. (1999). Thiazide induces water absorption in the inner medullary collecting duct of normal and Brattleboro rats. American Journal of Physiology, 277(5 Pt 2), F756–F760.PubMed
22.
Zurück zum Zitat Di Biase, L., Burkhardt, J. D., Mohanty, P., Sanchez, J., Mohanty, S., Horton, R., et al. (2010). Left atrial appendage: an underrecognized trigger site of atrial fibrillation. Circulation, 122(2), 109–118.PubMedCrossRef Di Biase, L., Burkhardt, J. D., Mohanty, P., Sanchez, J., Mohanty, S., Horton, R., et al. (2010). Left atrial appendage: an underrecognized trigger site of atrial fibrillation. Circulation, 122(2), 109–118.PubMedCrossRef
Metadaten
Titel
Electrolyte and hemodynamic changes following percutaneous left atrial appendage ligation with the LARIAT device
verfasst von
Ryan Maybrook
Jayasree Pillarisetti
Vivek Yarlagadda
Sampath Gunda
Arun Raghav Mahankali Sridhar
Brent Deibert
Muhammad R. Afzal
Madhu Reddy
Donita Atkins
Matthew Earnest
Ryan Ferrell
Jayant Nath
Arun Kanmanthareddy
Sudharani Bommana
Rajasingh Johnson
Sandeep Reddy Koripalli
Buddhadeb Dawn
Dhanunjaya Lakkireddy
Publikationsdatum
01.09.2015
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 3/2015
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-015-0012-6

Weitere Artikel der Ausgabe 3/2015

Journal of Interventional Cardiac Electrophysiology 3/2015 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.